Published in Cancer Sci on April 21, 2009
Geographical variation in cancer survival in England, 1991-2006: an analysis by Cancer Network. J Epidemiol Community Health (2011) 0.84
Characteristics of internal hernia after gastrectomy with Roux-en-Y reconstruction for gastric cancer. Surg Endosc (2014) 0.84
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol (2009) 4.44
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer (2004) 4.16
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89
Cancer survival in China, 2003-2005: a population-based study. Int J Cancer (2014) 3.32
Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut (2011) 3.07
Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer (2011) 2.97
National survey of British public's views on use of identifiable medical data by the National Cancer Registry. BMJ (2006) 2.92
Modeling smoking history: a comparison of different approaches. Am J Epidemiol (2002) 2.92
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol (2013) 2.84
Cancer survival in Kentucky and health insurance coverage. Arch Intern Med (2003) 2.61
Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol (2008) 2.25
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control (2013) 2.18
Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables. Biom J (2012) 2.06
An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol (2013) 1.89
Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol (2008) 1.85
Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer (2006) 1.83
Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol (2011) 1.77
Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol (2010) 1.67
Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health (2005) 1.66
Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol (2010) 1.65
Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy. Surgery (2009) 1.60
Childhood cancer survival in Europe and the United States. Cancer (2002) 1.59
Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer (2012) 1.54
Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer (2002) 1.51
Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol (2007) 1.50
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol (2012) 1.49
Survival from rare cancer in adults: a population-based study. Lancet Oncol (2006) 1.49
Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. Jpn J Clin Oncol (2008) 1.48
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol (2009) 1.43
Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol (2010) 1.36
Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol (2006) 1.35
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer (2006) 1.28
Survival from malignant digestive endocrine tumors in England and Wales: a population-based study. Gastroenterology (2007) 1.27
Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer (2012) 1.23
Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol (2009) 1.22
Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer (2014) 1.21
Trends in lung cancer incidence by histological type in Osaka, Japan. Jpn J Clin Oncol (2008) 1.20
A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol (2003) 1.20
Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology (2010) 1.19
Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study. Eur J Cancer (2006) 1.18
Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev (2007) 1.18
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med (2008) 1.16
Liver cancer and its prevention. Asian Pac J Cancer Prev (2005) 1.13
Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? J Magn Reson Imaging (2011) 1.12
Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori (2008) 1.11
Breast cancer survival in South Asian women in England and Wales. J Epidemiol Community Health (2005) 1.11
Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci (2012) 1.11
Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open (2013) 1.10
Trends in cancer survival in Spearhead Primary Care Trusts in England, 1998-2004. Health Stat Q (2009) 1.10
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer (2005) 1.10
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. Eur J Cancer (2011) 1.09
Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery (2006) 1.09
Cancer screening: evidence and practice in Europe 2008. Eur J Cancer (2008) 1.08
Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol (2004) 1.08
Socio-economic disparities in access to treatment and their impact on colorectal cancer survival. Int J Epidemiol (2010) 1.06
Cancer incidence in South Asian migrants to England, 1986-2004: unraveling ethnic from socioeconomic differentials. Int J Cancer (2012) 1.06
Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data. BMJ (2011) 1.06
Comparison of trends in cancer incidence and mortality in Osaka, Japan, using an age-period-cohort model. Asian Pac J Cancer Prev (2011) 1.05
The state of the art of cancer control in 30 European countries in 2008. Int J Cancer (2010) 1.04
Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol (2010) 1.03
Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol (2009) 1.03
Cancer control-planning and monitoring population-based systems. Tumori (2009) 1.02
Sample size determination in clinical trials with multiple co-primary binary endpoints. Stat Med (2010) 1.02
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol (2009) 1.01
Sample size determination for clinical trials with co-primary outcomes: exponential event times. Pharm Stat (2012) 1.00
Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study. Br J Haematol (2013) 1.00
Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health (2011) 0.99
Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol (2005) 0.99
Incidence and survival trends for childhood cancer in Osaka, Japan, 1973-2001. Cancer Sci (2009) 0.99
Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. Eur J Cancer (2008) 0.99